DK30391D0 - SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENT - Google Patents

SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENT

Info

Publication number
DK30391D0
DK30391D0 DK030391A DK30391A DK30391D0 DK 30391 D0 DK30391 D0 DK 30391D0 DK 030391 A DK030391 A DK 030391A DK 30391 A DK30391 A DK 30391A DK 30391 D0 DK30391 D0 DK 30391D0
Authority
DK
Denmark
Prior art keywords
cavitat
clatrate
substance consisting
guest complexes
contracting agent
Prior art date
Application number
DK030391A
Other languages
Danish (da)
Other versions
DK30391A (en
Inventor
Celal Albayrak
Georg Roessling
Johannes Tack
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of DK30391A publication Critical patent/DK30391A/en
Publication of DK30391D0 publication Critical patent/DK30391D0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0002—General or multifunctional contrast agents, e.g. chelated agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/189—Host-guest complexes, e.g. cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/22—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations
    • A61K49/222—Echographic preparations; Ultrasound imaging preparations ; Optoacoustic imaging preparations characterised by a special physical form, e.g. emulsions, liposomes
    • A61K49/228—Host-guest complexes, clathrates, chelates
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Abstract

The invention relates to the use of cavity- or clathrate-forming host/guest complexes as contrast media in ultrasonic, X-ray or NMR investigations.
DK030391A 1988-08-23 1991-02-21 SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENT DK30391D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3828905A DE3828905A1 (en) 1988-08-23 1988-08-23 MEDIALLY COMPOSED OF CAVITATE OR CLATHRATE MAKING HOST / GUEST COMPLEX AS A CONTRAST
PCT/DE1989/000548 WO1990001952A1 (en) 1988-08-23 1989-08-18 Contrast preparation consisting of cavitate- or clathrate-forming host/guest complexes

Publications (2)

Publication Number Publication Date
DK30391A DK30391A (en) 1991-02-21
DK30391D0 true DK30391D0 (en) 1991-02-21

Family

ID=6361599

Family Applications (1)

Application Number Title Priority Date Filing Date
DK030391A DK30391D0 (en) 1988-08-23 1991-02-21 SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENT

Country Status (12)

Country Link
EP (1) EP0357163B1 (en)
JP (1) JP3142539B2 (en)
AT (1) ATE76758T1 (en)
AU (1) AU641363B2 (en)
DE (2) DE3828905A1 (en)
DK (1) DK30391D0 (en)
ES (1) ES2042986T3 (en)
GR (1) GR3005457T3 (en)
IE (1) IE65168B1 (en)
NO (1) NO302101B1 (en)
PT (1) PT91501B (en)
WO (1) WO1990001952A1 (en)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922304A (en) 1989-12-22 1999-07-13 Imarx Pharmaceutical Corp. Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
US5542935A (en) 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US6001335A (en) 1989-12-22 1999-12-14 Imarx Pharmaceutical Corp. Contrasting agents for ultrasonic imaging and methods for preparing the same
US5580575A (en) 1989-12-22 1996-12-03 Imarx Pharmaceutical Corp. Therapeutic drug delivery systems
US5469854A (en) 1989-12-22 1995-11-28 Imarx Pharmaceutical Corp. Methods of preparing gas-filled liposomes
US6146657A (en) 1989-12-22 2000-11-14 Imarx Pharmaceutical Corp. Gas-filled lipid spheres for use in diagnostic and therapeutic applications
US6551576B1 (en) 1989-12-22 2003-04-22 Bristol-Myers Squibb Medical Imaging, Inc. Container with multi-phase composition for use in diagnostic and therapeutic applications
US5585112A (en) 1989-12-22 1996-12-17 Imarx Pharmaceutical Corp. Method of preparing gas and gaseous precursor-filled microspheres
US5776429A (en) 1989-12-22 1998-07-07 Imarx Pharmaceutical Corp. Method of preparing gas-filled microspheres using a lyophilized lipids
US6088613A (en) 1989-12-22 2000-07-11 Imarx Pharmaceutical Corp. Method of magnetic resonance focused surgical and therapeutic ultrasound
IN172208B (en) * 1990-04-02 1993-05-01 Sint Sa
US5445813A (en) 1992-11-02 1995-08-29 Bracco International B.V. Stable microbubble suspensions as enhancement agents for ultrasound echography
US5578292A (en) 1991-11-20 1996-11-26 Bracco International B.V. Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof
US5874062A (en) 1991-04-05 1999-02-23 Imarx Pharmaceutical Corp. Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
US5205290A (en) 1991-04-05 1993-04-27 Unger Evan C Low density microspheres and their use as contrast agents for computed tomography
ES2103376T3 (en) * 1991-07-05 1997-09-16 Nycomed Imaging As IMPROVEMENTS INTRODUCED IN CONTRAST AGENTS.
DE69230885T3 (en) * 1991-09-17 2008-01-24 Ge Healthcare As GASOUS ULTRASONIC CONTRASTING AGENTS
US5409688A (en) * 1991-09-17 1995-04-25 Sonus Pharmaceuticals, Inc. Gaseous ultrasound contrast media
US6723303B1 (en) 1991-09-17 2004-04-20 Amersham Health, As Ultrasound contrast agents including protein stabilized microspheres of perfluoropropane, perfluorobutane or perfluoropentane
MX9205298A (en) 1991-09-17 1993-05-01 Steven Carl Quay GASEOUS ULTRASOUND CONTRASTING MEDIA AND METHOD FOR SELECTING GASES TO BE USED AS ULTRASOUND CONTRASTING MEDIA
IL104084A (en) * 1992-01-24 1996-09-12 Bracco Int Bv Long-lasting aqueous suspensions of pressure-resistant gas-filled microvesicles their preparation and contrast agents consisting of them
WO1994016739A1 (en) * 1993-01-25 1994-08-04 Sonus Pharmaceuticals, Inc. Phase shift colloids as ultrasound contrast agents
IL108416A (en) 1993-01-25 1998-10-30 Sonus Pharma Inc Phase shift colloids as ultrasound contrast agents
US5558855A (en) * 1993-01-25 1996-09-24 Sonus Pharmaceuticals Phase shift colloids as ultrasound contrast agents
CN1061893C (en) * 1993-03-08 2001-02-14 柯铭清 Acoustical contrast agent
US5716597A (en) * 1993-06-04 1998-02-10 Molecular Biosystems, Inc. Emulsions as contrast agents and method of use
WO1995003835A1 (en) * 1993-07-30 1995-02-09 Alliance Pharmaceutical Corp. Stabilized microbubble compositions for ultrasound
US5798091A (en) 1993-07-30 1998-08-25 Alliance Pharmaceutical Corp. Stabilized gas emulsion containing phospholipid for ultrasound contrast enhancement
NZ276167A (en) 1993-12-15 1996-11-26 Bracco Research Sa Ultrasound contrast medium comprising two gases in aqueous suspension
US5545396A (en) 1994-04-08 1996-08-13 The Research Foundation Of State University Of New York Magnetic resonance imaging using hyperpolarized noble gases
US5622687A (en) * 1994-11-15 1997-04-22 Molecular Biosystems, Inc. Calixarene conjugates useful as MRI and CT diagnostic imaging agents
US6743779B1 (en) 1994-11-29 2004-06-01 Imarx Pharmaceutical Corp. Methods for delivering compounds into a cell
US5830430A (en) 1995-02-21 1998-11-03 Imarx Pharmaceutical Corp. Cationic lipids and the use thereof
US6231834B1 (en) 1995-06-07 2001-05-15 Imarx Pharmaceutical Corp. Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
US6139819A (en) 1995-06-07 2000-10-31 Imarx Pharmaceutical Corp. Targeted contrast agents for diagnostic and therapeutic use
US6033645A (en) 1996-06-19 2000-03-07 Unger; Evan C. Methods for diagnostic imaging by regulating the administration rate of a contrast agent
US6521211B1 (en) 1995-06-07 2003-02-18 Bristol-Myers Squibb Medical Imaging, Inc. Methods of imaging and treatment with targeted compositions
EP0766968B1 (en) * 1995-10-06 2001-01-17 Nihon Medi-Physics Co., Ltd. Diagnostic imaging agent
DE19543077C2 (en) * 1995-11-13 1997-10-16 Schering Ag Use of gas-containing metal complexes as ultrasound contrast agent
HU226714B1 (en) * 1996-03-05 2009-07-28 Acusphere Microencapsulated fluorinated gases for use as imaging agents
US5611344A (en) * 1996-03-05 1997-03-18 Acusphere, Inc. Microencapsulated fluorinated gases for use as imaging agents
DE69736981D1 (en) 1996-05-01 2007-01-04 Imarx Pharmaceutical Corp IN VITRO PROCESS FOR INTRODUCING NUCLEIC ACIDS INTO A CELL
US6414139B1 (en) 1996-09-03 2002-07-02 Imarx Therapeutics, Inc. Silicon amphiphilic compounds and the use thereof
US5846517A (en) 1996-09-11 1998-12-08 Imarx Pharmaceutical Corp. Methods for diagnostic imaging using a renal contrast agent and a vasodilator
DE19709704C2 (en) 1997-03-10 1999-11-04 Michael Georgieff Use of a liquid preparation of xenon for intravenous administration when inducing and / or maintaining anesthesia
US6090800A (en) 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
US6537246B1 (en) 1997-06-18 2003-03-25 Imarx Therapeutics, Inc. Oxygen delivery agents and uses for the same
US6143276A (en) 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
US6120751A (en) 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US6416740B1 (en) 1997-05-13 2002-07-09 Bristol-Myers Squibb Medical Imaging, Inc. Acoustically active drug delivery systems
US6548047B1 (en) 1997-09-15 2003-04-15 Bristol-Myers Squibb Medical Imaging, Inc. Thermal preactivation of gaseous precursor filled compositions
US6123923A (en) 1997-12-18 2000-09-26 Imarx Pharmaceutical Corp. Optoacoustic contrast agents and methods for their use
US20010003580A1 (en) 1998-01-14 2001-06-14 Poh K. Hui Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
US6284222B1 (en) 1998-11-03 2001-09-04 Medi--Physics, Inc. Hyperpolarized helium-3 microbubble gas entrapment methods
DE19851605A1 (en) * 1998-11-09 2000-05-11 Messer Griesheim Gmbh Injection anesthetic containing microparticles
JP4544551B2 (en) * 1999-07-28 2010-09-15 日本曹達株式会社 Molecular compounds containing tri-o-thymotides as component compounds
AU2002220881A1 (en) * 2000-12-04 2002-06-18 Uws Ventures Limited Noble gas complexes
US8012457B2 (en) 2004-06-04 2011-09-06 Acusphere, Inc. Ultrasound contrast agent dosage formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276885A (en) * 1979-05-04 1981-07-07 Rasor Associates, Inc Ultrasonic image enhancement
US4718433A (en) * 1983-01-27 1988-01-12 Feinstein Steven B Contrast agents for ultrasonic imaging
DE3637926C1 (en) * 1986-11-05 1987-11-26 Schering Ag Ultrasonic manometry in a liquid using microbubbles

Also Published As

Publication number Publication date
AU641363B2 (en) 1993-09-23
PT91501A (en) 1990-03-08
NO910711L (en) 1991-02-22
NO302101B1 (en) 1998-01-26
DK30391A (en) 1991-02-21
ATE76758T1 (en) 1992-06-15
DE3828905A1 (en) 1990-03-15
IE892685L (en) 1990-02-23
JP3142539B2 (en) 2001-03-07
JPH04501559A (en) 1992-03-19
DE58901585D1 (en) 1992-07-09
WO1990001952A1 (en) 1990-03-08
GR3005457T3 (en) 1993-05-24
EP0357163B1 (en) 1992-06-03
IE65168B1 (en) 1995-10-04
EP0357163A1 (en) 1990-03-07
ES2042986T3 (en) 1993-12-16
NO910711D0 (en) 1991-02-22
AU4065189A (en) 1990-03-23
PT91501B (en) 1995-05-31

Similar Documents

Publication Publication Date Title
DK30391A (en) SUBSTANCE CONSISTING OF CAVITAT OR CLATRATE CREATING HOST / GUEST COMPLEXES AS CONTRACTING AGENT
NO161366C (en) NEW 1,3-CYCL HEXANDON DERIVATIVES AND USE THEREOF AS HERBICID AGENT.
DE3485162D1 (en) AMINOMETHYLOXOOXAZOLIDINYL-BENZOL DERIVATIVES USED AS ANTIBACTERIAL AGENTS.
IT8419216A0 (en) MEDICAL INSTRUMENT.
NO910399L (en) USE OF TRIALCANOLAMINE POLYETERS AS DEMULGATORS FOR OIL-IN-WATER EMULSIONS.
ATE89169T1 (en) AGENT CONTAINING ANTICOAGULANT.
DK0557345T3 (en) 1,3-bis- (3- (mono- or polyhydroxy) acylamino-5- (mono- or polyhydroxyalkyl) aminocarbonyl-2,4,6-triiodobenzoylamino) -hydroxy- or hydroxyalkyl-propanes, processes for their preparation and X-ray contrast agents containing these
DK137945B (en) Triiodobenzene derivatives for use as X-ray contrast agents.
ATE115848T1 (en) SYRINGE DEVICE FOR LIQUID MIXTURES, PARTICULARLY FOR DENTAL PURPOSES.
DE3875675T2 (en) ASYMMETRIC S.P.E.C.T. Collimator that surrounds the patient.
DE59104783D1 (en) Patient examination table.
NO901452L (en) MIXTURES CONTAINING 2-TIOCYANO-METHYLTIO-BENZOTIAZOL FOR USE AS INDUSTRIAL MICROBIOCIDS.
ES2039211T3 (en) NEW N-GLYCOSILAMIDODERIVES, PROCEDURES FOR THEIR OBTAINING AND USE AS MEDICINES.
ATE130304T1 (en) NEW ALPHA-GLUCOSIDASINE INHIBITORS.
SE7713700L (en) 2-SUBSTITUTED-1- (OMEGA-AMINOALCOXI) BENSENER
DK165789C (en) 4-OXO-4H-PYRIMIDOOE2,1, AAAISOQUINOLINE DERIVATIVES, ANALOGUE PROCEDURES FOR PREPARING THEREOF, PHARMACEUTICAL PREPARATION CONTAINING THESE, AND THE DERIVATIVES FOR USE AS ANTI-ANALYSIS
FI910076A0 (en) PAOSE FOER FOERBRUKADE, VID SURGICAL OPERATIONER ANVAENDA ENGAONGSARTIKLAR, SAOSOM OPERATIONSDUKAR OCH KOMPRESSER.
DE3485217D1 (en) BLOOD PRESSURE COMPOSITION.
IT8323615V0 (en) WORKTOP WITH REMOVABLE INCORPORATED NEGATOSCOPE, PARTICULARLY FOR MEDICAL USE.
NO903703L (en) GEL MATERIALS CONTAINING SUSPENSIVE AGENT.
IT8884903A0 (en) CATHETER FOR MEDICAL USE.
IT215357Z2 (en) RULE PARTICULARLY FOR CLINICAL USE.
IT8385603A0 (en) ARM SUPPORT FOR SURGICAL USE.
DK0739637T3 (en) Medical instrument.
ES267479Y (en) "PERFECTED SAMPLE CASE, CARRIER OF REMOVABLE MODELS FOR THE CONFORMATION OF FURNITURE".

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment